|
||||||||||||
 |
||||||||||||
|
||||||||||||
Top Stories
Immunize.org Website and Clinical Resources
Featured Resources
Global News Upcoming Events
Top Stories
“Use of Inactivated Polio Vaccine among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices—United States, 2023” published in MMWR
CDC published Use of Inactivated Polio Vaccine among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices—United States, 2023 on December 8 in MMWR. A portion of the summary appears below. On June 21, 2023, the Advisory Committee on Immunization Practices issued an IPV recommendation for all adults known or suspected to be unvaccinated or incompletely vaccinated against polio. Risk-based recommendations for IPV boosters have not changed. . . . Adults aged ≥18 years who are known or suspected to be unvaccinated or incompletely vaccinated against polio should complete a primary polio vaccination series with IPV. Fully vaccinated adults at increased risk for poliovirus exposure may receive a single lifetime booster dose of IPV. Access the MMWR article in HTML or PDF.
Back to top
“Polio Vaccination of Adults”: watch the 2-minute answer, part of the Ask the Experts Video Series on Facebook, LinkedIn, X, YouTube, and Instagram This week, our featured episode from the Ask the Experts Video Series is Polio Vaccination of Adults. The video briefly describes the new ACIP recommendations described in the MMWR published last week. It is available on our YouTube channel, along with our full collection of quick video answers to popular Ask the Experts questions. Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise:
Immunize.org posts 11 additional translations of COVID-19 and RSV VISs, and RSV Preventive Antibody Immunization Information Statement Thanks to CDC support, Immunize.org continues to expand its repository of VIS translations. Last week, Immunize.org posted 11 more up-to-date translations for COVID-19 and RSV VISs and the RSV Preventive Antibody Immunization Information Statement (IIS). The following table shows the languages available; the 11 new translations appear in bold print. To ensure you have the current translations, click on Vaccines & VISs at Immunize.org, then click on VISs, then select a specific vaccine. Scrolling down the resulting page, you will see the current English version, a list of current translations (i.e., corresponding to the current English VIS), and then, if applicable, a list of any out-of-date (yet best available) translations. Additional tips on using VISs appear at the bottom of the page.
On December 7, CDC released the first VIS for tick-borne encephalitis. Immunize.org added the Tick-Borne Encephalitis (TBE) VIS to our website. TBE vaccine is indicated for certain travelers at risk of tick exposure in regions of central Europe or Asia where TBE is endemic.
Related Links
Review your COVID-19 resources with the latest version of Immunize.org’s “Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools” Immunize.org reviews and updates the Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools at least monthly, prominently indicating when it was last revised at the top of the page. The December 3 checklist includes a link to a searchable list of MMWR articles about COVID-19 vaccination. It also includes a change in the prevaccination checklists section to show CDC’s English version for providers and Spanish version for recipients. CDC now refers COVID-19 vaccine providers to Immunize.org's English version of screening checklists for contraindications to vaccination for children or adults. All COVID-19 vaccine providers should review the checklist regularly and download the latest CDC schedule and standing order documents. Discard any outdated versions of cited documents. The checklist is posted on Immunize.org's Vaccines A–Z: COVID-19 main page to help practices stay up to date.
CDC’s Weekly U.S. Influenza Surveillance Report, FluView, provides a valuable picture of laboratory-confirmed influenza and influenza-like illness activity state by state. Influenza Vaccination Dashboard
Immunize.org updates parent handout "When Do Children and Teens Need Vaccinations?" to include RSV preventive antibody
Immunize.org recently updated When Do Children and Teens Need Vaccinations? handout to include a new column for RSV preventive antibody and an explanatory note. A QR code linking to the online version of the document was also added.
Related Links
Immunize.org recently updated How to Administer Multiple Intramuscular Vaccines to Adults during One Visit to incorporate RSV into the list of vaccines commonly administered to adults. Related Links
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
Immunize.org Website and Clinical Resources
Put a bow on it! Show your vaccination support with Immunize.org’s “Save Lives. Immunize.” branded mugs, T-shirts, and pins.
Show your vaccination support with Immunize.org's new "Save Lives. Immunize." branded mugs, T-shirts, and pins.
Back to top
Immunize.org recently updated two of its resources, Polio: Questions and Answers and Rotavirus: Questions and Answers. Changes are described below.
Related Links
Featured Resources
V-safe, CDC’s voluntary smartphone-based vaccine safety monitoring system, was originally developed to monitor COVID-19 vaccine safety. Now, it has been adapted to collect data for RSV vaccination of two groups:
After RSV vaccination, participants may choose to enroll in V-safe. They will then receive brief, confidential surveys via text messages or emails.
Back to top
NFID posts podcast featuring Peter J. Hotez, MD, PhD, on how to counter anti-science rhetoric and build vaccine confidence Infectious IDeas, a podcast series from NFID, brings leading experts together for thought-provoking conversations. The latest entry in the series, Building Global Vaccine Confidence through Diplomacy, features Peter J. Hotez, MD, PhD. A description from the web page appears below. In this episode, hosts Marla Dalton, PE, CAE, and William Schaffner, MD, talk with Peter J. Hotez, MD, PhD, dean of the National School of Tropical Medicine at Baylor College of Medicine. He shares insights from his influential career in vaccine science and diplomacy, from how the field has changed over time, how his experience as the father of an autistic daughter helped shape his career, and what we can all be doing to counter anti-science rhetoric and help build vaccine confidence. Back to top
North Dakota State University Center for Immunization Research and Education posts archived recording of webinar on new products to prevent RSV The North Dakota State University (NDSU) Center for Immunization Research and Education (CIRE), Jefferson Jones, MD, MPH, and Jennifer DeCuir, MD, PhD, hosted a webinar discussing the new RSV prevention tools on December 11. The webinar focused on the epidemiology of RSV in children and adults, as well as the benefits and risks of RSV vaccines and monoclonal antibody. Global News
CDC published Progress in Immunization Safety Monitoring—Worldwide, 2020–2022 on December 8 in MMWR. A portion of the summary appears below. In 2020, the World Health Organization (WHO) recommended a new case-based vaccine safety monitoring indicator: one or more serious adverse events following immunization (AEFIs) per 1 million total population per year. . . . In 2022, 92 (43%) of 215 WHO-affiliated countries and territories achieved the new case-based indicator. During 2020–2022, four of six WHO regions reported an increase in joint reporting of national AEFI data from national regulatory authorities (NRAs) and national expanded programs on immunization (EPIs). . . . Case-based reporting promotes timely AEFI detection, reporting, investigation, and response by NRAs and EPIs. Improving case-based data sharing globally can provide valuable insights into trends and regional characteristics of serious AEFI.
Upcoming Events
Virtual: Moderna hosts “Vaccinating against COVID-19 in Black and Hispanic Communities: Important Information for Healthcare Providers” on December 14 at 12:00 p.m. (ET)
Moderna will host a webinar titled Vaccinating against COVID-19 in Black and Hispanic Communities: Important Information for Healthcare Providers at 12:00 p.m. (ET) on December 14. Moderna’s Medical Affairs Diversity Panel will discuss the importance of staying up to date with COVID-19 vaccines within communities of color this holiday season. They will also discuss COVID-19’s effect on Black and Hispanic communities, the most recent ACIP recommendations, and common COVID-19 vaccine myths that may decrease vaccine confidence. Virtual: NFID offers archived “2023 Clinical Vaccinology Course” through January 31; fee to register (CE credit available)
NFID offers an archived version of its November 2023 Clinical Vaccinology Course online through January 31. This course focuses on new developments and issues related to the use of vaccines. Expert faculty provide the latest information on vaccines, including updated recommendations for vaccinations across the lifespan, and practical, innovative strategies for timely vaccination. View event details. For more upcoming events, visit our Calendar of Events.
|
||||||||||||
|
